Newly Approved HIV Test Can Spot Infection Earlier

This article has not necessarily been edited by Health24.

MONDAY, June 21 (HealthDay News) -- Abbott's Architect HIV Ag/Ab Combo assay has been approved by the U.S. Food and Drug Administration.

Traditional HIV diagnostics have detected HIV antibodies, which are developed days after an infection as a sign that the body is working to fight the invading virus. The Architect assay also detects the HIV p24 antigen, which is a protein produced by the virus immediately after infection, Abbott said in a news release.

The risk of HIV transmission is highest just after infection with the AIDS-causing virus, the company said.

Since the new test could detect HIV infection days earlier than antibody-only diagnostics, people could be alerted before unknowingly spreading the infection and be treated earlier, Abbott said.

Some 56,000 new cases of HIV infection are diagnosed each year in the United States, the Illinois-based company said, citing the U.S. Centers for Disease Control and Prevention.

More information

To learn more about HIV / AIDS, visit AIDS.gov.

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For only R75 per month, you have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today.
Subscribe to News24
Voting Booth
Have you entered our Health of the Nation survey?
Please select an option Oops! Something went wrong, please try again later.
Results
Yes
33% - 9320 votes
No
67% - 18609 votes
Vote